schliessen

Filtern

 

Bibliotheken

The economic impact of visceral leishmaniasis on households in Bangladesh

To explore current patterns of diagnosis and treatment, quantify household economic impact and identify household strategies to cover the costs of visceral leishmaniasis (VL) care in rural Bangladesh. Structured interviews with 113 VL patients from 87 households documenting all provider visits and e... Full description

Journal Title: Tropical Medicine & International Health May 2006, Vol.11(5), pp.757-764
Main Author: Anoopa Sharma, D.
Other Authors: Bern, Caryn , Varghese, Beena , Chowdhury, Rajib , Haque, Rashidul , Ali, Mustakim , Amann, Josef , Ahluwalia, Indu B. , Wagatsuma, Yukiko , Breiman, Robert F. , Maguire, James H. , Mcfarland, Deborah A.
Format: Electronic Article Electronic Article
Language: fre ; spa
Subjects:
ID: ISSN: 1360-2276 ; E-ISSN: 1365-3156 ; DOI: 10.1111/j.1365-3156.2006.01604.x
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: wj10.1111/j.1365-3156.2006.01604.x
title: The economic impact of visceral leishmaniasis on households in Bangladesh
format: Article
creator:
  • Anoopa Sharma, D.
  • Bern, Caryn
  • Varghese, Beena
  • Chowdhury, Rajib
  • Haque, Rashidul
  • Ali, Mustakim
  • Amann, Josef
  • Ahluwalia, Indu B.
  • Wagatsuma, Yukiko
  • Breiman, Robert F.
  • Maguire, James H.
  • Mcfarland, Deborah A.
subjects:
  • Bangladesh
  • Coping Strategy
  • Economic Burden
  • Treatment Cost
  • Visceral Leishmaniasis
  • Leishmaniose Viscérale
  • Coût Du Traitement
  • Stratégie Pour Faire Face
  • Poids Économique
  • Bangladesh
  • Leishmaniasis Visceral
  • Costo De Tratamiento
  • Estrategia
  • Carga Económica
  • Bangladesh
ispartof: Tropical Medicine & International Health, May 2006, Vol.11(5), pp.757-764
description: To explore current patterns of diagnosis and treatment, quantify household economic impact and identify household strategies to cover the costs of visceral leishmaniasis (VL) care in rural Bangladesh. Structured interviews with 113 VL patients from 87 households documenting all provider visits and expenditures for health care for VL, and the ways in which the expenditures were covered. Patients paid a median of 7 visits to six different providers before beginning VL treatment. All visited the subdistrict government hospital at least once. While health care, including antileishmanial drug therapy, is officially available free of charge at government facilities, 79% of patients reported making informal payments for provider access, diagnostics and drug administration; only 14% of patients received their full drug course from this source. For the 58% of patients who purchased the full treatment course, drug cost constituted 34% of direct expenditure. Median direct expenditure for one VL patient was US$87 and median income lost was $40; median total expenditure was 1.2 times annual per capita income of our study population. Households employed multiple coping strategies to cover expenditures, most commonly sale or rental of assets (62%) and taking out loans (64%). Visceral leishmaniasis treatment causes a major economic burden in affected families. Control strategies for VL should facilitate timely, affordable diagnosis and treatment of patients to decrease the infection reservoir and to alleviate the economic burden of VL on households.
language: fre ; spa
source:
identifier: ISSN: 1360-2276 ; E-ISSN: 1365-3156 ; DOI: 10.1111/j.1365-3156.2006.01604.x
fulltext: fulltext
issn:
  • 1360-2276
  • 13602276
  • 1365-3156
  • 13653156
url: Link


@attributes
ID886915978
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid10.1111/j.1365-3156.2006.01604.x
sourceidwj
recordidTN_wj10.1111/j.1365-3156.2006.01604.x
sourcesystemOther
pqid67908775
galeid158876745
display
typearticle
title
0The economic impact of visceral leishmaniasis on households in Bangladesh
1Impacte économique de la leishmaniose viscérale sur les familles au Bengladesh
2El impacto económico de la leishmaniasis visceral en hogares de Bangladesh
creatorAnoopa Sharma, D. ; Bern, Caryn ; Varghese, Beena ; Chowdhury, Rajib ; Haque, Rashidul ; Ali, Mustakim ; Amann, Josef ; Ahluwalia, Indu B. ; Wagatsuma, Yukiko ; Breiman, Robert F. ; Maguire, James H. ; Mcfarland, Deborah A.
ispartofTropical Medicine & International Health, May 2006, Vol.11(5), pp.757-764
identifier
subjectBangladesh ; Coping Strategy ; Economic Burden ; Treatment Cost ; Visceral Leishmaniasis ; Leishmaniose Viscérale ; Coût Du Traitement ; Stratégie Pour Faire Face ; Poids Économique ; Bangladesh ; Leishmaniasis Visceral ; Costo De Tratamiento ; Estrategia ; Carga Económica ; Bangladesh
descriptionTo explore current patterns of diagnosis and treatment, quantify household economic impact and identify household strategies to cover the costs of visceral leishmaniasis (VL) care in rural Bangladesh. Structured interviews with 113 VL patients from 87 households documenting all provider visits and expenditures for health care for VL, and the ways in which the expenditures were covered. Patients paid a median of 7 visits to six different providers before beginning VL treatment. All visited the subdistrict government hospital at least once. While health care, including antileishmanial drug therapy, is officially available free of charge at government facilities, 79% of patients reported making informal payments for provider access, diagnostics and drug administration; only 14% of patients received their full drug course from this source. For the 58% of patients who purchased the full treatment course, drug cost constituted 34% of direct expenditure. Median direct expenditure for one VL patient was US$87 and median income lost was $40; median total expenditure was 1.2 times annual per capita income of our study population. Households employed multiple coping strategies to cover expenditures, most commonly sale or rental of assets (62%) and taking out loans (64%). Visceral leishmaniasis treatment causes a major economic burden in affected families. Control strategies for VL should facilitate timely, affordable diagnosis and treatment of patients to decrease the infection reservoir and to alleviate the economic burden of VL on households.
languagefre ; spa
source
version8
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
search
creatorcontrib
0Anoopa Sharma, D.
1Bern, Caryn
2Varghese, Beena
3Chowdhury, Rajib
4Haque, Rashidul
5Ali, Mustakim
6Amann, Josef
7Ahluwalia, Indu B.
8Wagatsuma, Yukiko
9Breiman, Robert F.
10Maguire, James H.
11Mcfarland, Deborah A.
title
0The economic impact of visceral leishmaniasis on households in Bangladesh
1Impacte économique de la leishmaniose viscérale sur les familles au Bengladesh
2El impacto económico de la leishmaniasis visceral en hogares de Bangladesh
descriptionTo explore current patterns of diagnosis and treatment, quantify household economic impact and identify household strategies to cover the costs of visceral leishmaniasis (VL) care in rural Bangladesh. Structured interviews with 113 VL patients from 87 households documenting all provider visits and expenditures for health care for VL, and the ways in which the expenditures were covered. Patients paid a median of 7 visits to six different providers before beginning VL treatment. All visited the subdistrict government hospital at least once. While health care, including antileishmanial drug therapy, is officially available free of charge at government facilities, 79% of patients reported making informal payments for provider access, diagnostics and drug administration; only 14% of patients received their full drug course from this source. For the 58% of patients who purchased the full treatment course, drug cost constituted 34% of direct expenditure. Median direct expenditure for one VL patient was US$87 and median income lost was $40; median total expenditure was 1.2 times annual per capita income of our study population. Households employed multiple coping strategies to cover expenditures, most commonly sale or rental of assets (62%) and taking out loans (64%). Visceral leishmaniasis treatment causes a major economic burden in affected families. Control strategies for VL should facilitate timely, affordable diagnosis and treatment of patients to decrease the infection reservoir and to alleviate the economic burden of VL on households.
subject
0Bangladesh
1Coping Strategy
2Economic Burden
3Treatment Cost
4Visceral Leishmaniasis
5Leishmaniose Viscérale
6Coût Du Traitement
7Stratégie Pour Faire Face
8Poids Économique
9Leishmaniasis Visceral
10Costo De Tratamiento
11Estrategia
12Carga Económica
general
0Blackwell Publishing Ltd
110.1111/j.1365-3156.2006.01604.x
2Wiley Online Library
sourceidwj
recordidwj10.1111/j.1365-3156.2006.01604.x
issn
01360-2276
113602276
21365-3156
313653156
rsrctypearticle
creationdate2006
addtitleTropical Medicine & International Health
searchscope
0wj
1wiley
scope
0wj
1wiley
lsr30VSR-Enriched:[pages, pqid, galeid]
sort
titleThe economic impact of visceral leishmaniasis on households in Bangladesh
authorAnoopa Sharma, D. ; Bern, Caryn ; Varghese, Beena ; Chowdhury, Rajib ; Haque, Rashidul ; Ali, Mustakim ; Amann, Josef ; Ahluwalia, Indu B. ; Wagatsuma, Yukiko ; Breiman, Robert F. ; Maguire, James H. ; Mcfarland, Deborah A.
creationdate20060500
facets
frbrgroupid4452593143712908086
frbrtype5
language
0fre
1spa
creationdate2006
topic
0Bangladesh
1Coping Strategy
2Economic Burden
3Treatment Cost
4Visceral Leishmaniasis
5Leishmaniose Viscérale
6Coût Du Traitement
7Stratégie Pour Faire Face
8Poids Économique
9Leishmaniasis Visceral
10Costo De Tratamiento
11Estrategia
12Carga Económica
collectionWiley Online Library
prefilterarticles
rsrctypearticles
creatorcontrib
0Anoopa Sharma, D.
1Bern, Caryn
2Varghese, Beena
3Chowdhury, Rajib
4Haque, Rashidul
5Ali, Mustakim
6Amann, Josef
7Ahluwalia, Indu B.
8Wagatsuma, Yukiko
9Breiman, Robert F.
10Maguire, James H.
11Mcfarland, Deborah A.
jtitleTropical Medicine & International Health
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Anoopa Sharma
1Bern
2Varghese
3Chowdhury
4Haque
5Ali
6Amann
7Ahluwalia
8Wagatsuma
9Breiman
10Maguire
11McFarland
aufirst
0D.
1Caryn
2Beena
3Rajib
4Rashidul
5Mustakim
6Josef
7Indu B.
8Yukiko
9Robert F.
10James H.
11Deborah A.
au
0Anoopa Sharma, D.
1Bern, Caryn
2Varghese, Beena
3Chowdhury, Rajib
4Haque, Rashidul
5Ali, Mustakim
6Amann, Josef
7Ahluwalia, Indu B.
8Wagatsuma, Yukiko
9Breiman, Robert F.
10Maguire, James H.
11Mcfarland, Deborah A.
atitle
0The economic impact of visceral leishmaniasis on households in Bangladesh
1Impacte économique de la leishmaniose viscérale sur les familles au Bengladesh
2El impacto económico de la leishmaniasis visceral en hogares de Bangladesh
jtitleTropical Medicine & International Health
risdate200605
volume11
issue5
spage757
epage764
issn1360-2276
eissn1365-3156
genrearticle
ristypeJOUR
abstractTo explore current patterns of diagnosis and treatment, quantify household economic impact and identify household strategies to cover the costs of visceral leishmaniasis (VL) care in rural Bangladesh. Structured interviews with 113 VL patients from 87 households documenting all provider visits and expenditures for health care for VL, and the ways in which the expenditures were covered. Patients paid a median of 7 visits to six different providers before beginning VL treatment. All visited the subdistrict government hospital at least once. While health care, including antileishmanial drug therapy, is officially available free of charge at government facilities, 79% of patients reported making informal payments for provider access, diagnostics and drug administration; only 14% of patients received their full drug course from this source. For the 58% of patients who purchased the full treatment course, drug cost constituted 34% of direct expenditure. Median direct expenditure for one VL patient was US$87 and median income lost was $40; median total expenditure was 1.2 times annual per capita income of our study population. Households employed multiple coping strategies to cover expenditures, most commonly sale or rental of assets (62%) and taking out loans (64%). Visceral leishmaniasis treatment causes a major economic burden in affected families. Control strategies for VL should facilitate timely, affordable diagnosis and treatment of patients to decrease the infection reservoir and to alleviate the economic burden of VL on households.
copOxford, UK
pubBlackwell Publishing Ltd
doi10.1111/j.1365-3156.2006.01604.x
pages757-764
date2006-05